Shift Bioscience Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $10.9M

  • Investors
  • 13

Shift Bioscience General Information

Description

Developer of cell rejuvenation therapeutics designed to reverse cellular aging without altering cell identity. The company offers an AI-driven discovery platform integrating single-cell sequencing, aging clocks, and virtual cell models, enabling biotechnology and pharmaceutical researchers to identify therapeutic targets and develop safer treatments for age-related diseases.

Contact Information

Formerly Known As
Nextneural
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Gurdon Institute Tennis Court Road
  • Cambridge CB2 1QN
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • The Gurdon Institute Tennis Court Road
  • Cambridge CB2 1QN
  • England, United Kingdom

Shift Bioscience Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shift Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Seed Round 11-Jun-2024 $10.9M Completed Startup
7. Accelerator/Incubator 30-Nov-2023 Completed Startup
6. Seed Round 21-Sep-2022 Completed Startup
5. Seed Round 16-Dec-2021 Completed Startup
4. Accelerator/Incubator 21-May-2019 Completed Startup
3. Seed Round 11-Apr-2019 Completed Startup
2. Seed Round 28-Sep-2018 $163K $486K Completed Startup
1. Seed Round 20-Jul-2017 $323K $323K Completed Startup
To view Shift Bioscience’s complete valuation and funding history, request access »

Shift Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 3,334 $0.000013 $47.67 $47.67 1x $47.67 1.16%
Ordinary 20,000 $0.000013 $15.89 $15.89 1x $15.89 6.94%
To view Shift Bioscience’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Shift Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell rejuvenation therapeutics designed to reverse cellular aging without altering cell identity. The compa
Drug Discovery
Cambridge, United Kingdom
26 As of 2026

San Francisco, CA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Shift Bioscience Competitors (5)

One of Shift Bioscience’s 5 competitors is Retro, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Retro Venture Capital-Backed San Francisco, CA
NewLimit Venture Capital-Backed South San Francisco, CA
clock.health Formerly VC-backed Cambridge, United Kingdom
Life Biosciences Venture Capital-Backed Boston, MA
Altos Labs Private Equity-Backed Redwood City, CA
You’re viewing 5 of 5 competitors. Get the full list »

Shift Bioscience Patents

Shift Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202511336-D0 Compositions and methods Pending 14-Jul-2025
GB-202508914-D0 Compositions and methods Pending 06-Jun-2025
GB-202508655-D0 Compositions and methods Inactive 02-Jun-2025
GB-202508119-D0 Compositions and methods Inactive 23-May-2025
GB-202507586-D0 Compositions and methods Inactive 16-May-2025
To view Shift Bioscience’s complete patent history, request access »

Shift Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shift Bioscience Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
IKJ Capital Venture Capital Minority
Frame Shift Bio-Incubator Accelerator/Incubator
BGF (Financial Services) Growth/Expansion Minority
Boost VC Accelerator/Incubator Minority
F-Prime Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Shift Bioscience FAQs

  • When was Shift Bioscience founded?

    Shift Bioscience was founded in 2017.

  • Where is Shift Bioscience headquartered?

    Shift Bioscience is headquartered in Cambridge, United Kingdom.

  • What is the size of Shift Bioscience?

    Shift Bioscience has 26 total employees.

  • What industry is Shift Bioscience in?

    Shift Bioscience’s primary industry is Drug Discovery.

  • Is Shift Bioscience a private or public company?

    Shift Bioscience is a Private company.

  • What is the current valuation of Shift Bioscience?

    The current valuation of Shift Bioscience is .

  • What is Shift Bioscience’s current revenue?

    The current revenue for Shift Bioscience is .

  • How much funding has Shift Bioscience raised over time?

    Shift Bioscience has raised $17.5M.

  • Who are Shift Bioscience’s investors?

    IKJ Capital, Frame Shift Bio-Incubator, BGF (Financial Services), Boost VC, and F-Prime are 5 of 13 investors who have invested in Shift Bioscience.

  • Who are Shift Bioscience’s competitors?

    Retro, NewLimit, clock.health, Life Biosciences, and Altos Labs are competitors of Shift Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process